EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction

Shingo Matsumoto, Jawad H Butt, Kieran F Docherty, Pardeep S Jhund iD, William T Abraham, Akshay S Desai iD, Lars Kober, Jean L Rouleau, Milton Packer iD, Muthiah Vaduganathan iD, Scott D Solomon, John J V McMurray iD

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvaf235 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Shingo Matsumoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, Scotland G12 8TA, United Kingdom. Hauptthemen laut MEDLINE: Aldosterone, Heart Failure, Natriuretic Peptide, Brain, Obesity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PARADIGM-HF, ATMOSPHERE, Novartis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Experimental evidence suggests that adipose tissue may secrete aldosterone, and mineralocorticoid receptor antagonists (MRAs) appear to be more effective in patients with obesity. Therefore, we examined aldosterone levels according to measures of adiposity in patients with heart failure and reduced ejection fraction (HFrEF) participating in two large trials. Methods and results Aldosterone, N-terminal pro B-type natriuretic peptide (NT-proBNP), and B-type natriuretic peptide (BNP) levels were compared according to body mass index (BMI) categories: normal weight (<25.0 kg/m2), overweight (25.0–29.9 kg/m2), obesity class I (30.0–34.9 kg/m2), and obesity class II/III (≥35.0 kg/m2). Of the 2201 patients not treated with an MRA, in whom aldosterone levels were measured at baseline in ATMOSPHERE and PARADIGM-HF, the mean age was 67.8 years, and 440 (20.0%) were female. Patients with higher BMI had a higher left ventricular ejection fraction but worse New York Heart Association functional class than those with normal weight. Higher BMI was associated with higher aldosterone levels but lower NT-proBNP and BNP levels (P for trend < 0.001), compared to those with normal weight. This natriuretic peptide trend was also seen for other anthropometric measures.

Conclusion

Greater adiposity was associated with higher concentrations of aldosterone but lower levels of B-type natriuretic peptides in patients with HFrEF. Adipose tissue may influence the neurohumoral milieu in HFrEF, including the secretion of aldosterone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldosteroneHeart FailureNatriuretic Peptide, BrainObesityStroke VolumePeptide FragmentsVentricular Function, LeftHumansFemaleMaleAgedMiddle AgedBiomarkersAdiposityBody Mass IndexMineralocorticoid Receptor Antagonists

Stichwörter der Autor:innen

AldosteroneHeart failure with reduced ejection fraction (HFrEF)Natriuretic peptideObesity

Substanzen

AldosteroneNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)BiomarkersPeptide FragmentsMineralocorticoid Receptor Antagonists

Autor:innen und Institutionen

  • British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, Scotland G12 8TA, United Kingdom.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University, Faculty of Medicine, Tokyo 143-8540, Japan.
  • Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Department of Cardiology, Zealand University Hospital, Roskilde 4000, Denmark.
  • Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA.

ORCID-Profile: Pardeep S Jhund, Akshay S Desai, Milton Packer, Muthiah Vaduganathan, John J V McMurray

Förderung

  • PARADIGM-HF
  • ATMOSPHERE
  • Novartis

Zitieren

APA

Matsumoto, S., Butt, J. H., Docherty, K. F., Jhund, P. S., Abraham, W. T., Desai, A. S., Kober, L., Rouleau, J. L., Packer, M., Vaduganathan, M., Solomon, S. D., & McMurray, J. J. V. (2026). Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf235

Vancouver

Matsumoto S, Butt JH, Docherty KF, Jhund PS, Abraham WT, Desai AS, et al. Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction. Cardiovascular Research. 2026. doi:10.1093/cvr/cvaf235

BibTeX
@article{Matsumoto2026,
  author = {Matsumoto, Shingo and Butt, Jawad H and Docherty, Kieran F and Jhund, Pardeep S and Abraham, William T and Desai, Akshay S and Kober, Lars and Rouleau, Jean L and Packer, Milton and Vaduganathan, Muthiah and Solomon, Scott D and McMurray, John J V},
  title = {Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvaf235}
}
Kostenlos starten →